Download Files:
DHODH-IN-22
SKU
HY-149031-Get quote
Category Reference compound
Tags Cancer, Dihydroorotate Dehydrogenase, Metabolic Enzyme/Protease
Products Details
Product Description
– DHODH-IN-22 is a potent, selective and orally active dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 value of 0.3 nM. DHODH-IN-22 can be used for researching acute myelogenous leukemia (AML)[1].
Web ID
– HY-149031
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C21H21ClF4N6O5
References
– [1]Cisar JS, et al. N-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia. J Med Chem. 2022 Aug 4.
CAS Number
– 2450341-75-8
Molecular Weight
– 548.88
SMILES
– O=C(C1=CC(F)=C(N2N=C(CO)N(CC)C2=O)N=C1O[C@@H](C)C(F)(F)F)NC3=C(Cl)C(OC)=NC=C3C
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Dihydroorotate Dehydrogenase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.